Skip to main content

Table 2 (abstract P40). Remission rates in respect to different treatment modalities.

From: 9th European Conference on Rare Diseases & Orphan Products (ECRD Vienna 2018)

Mode of treatment Remission rates (% of patients) Total number of patients
Overall 51.4 534
Overall after introduction of SSA 70.3 219
Surgery 28.8 486
Adjuvant CAB without prior Ro 18.2 70
Adjuvant SSA 38.6 70
Conventional radiotherapy 34.6 159
  1. CAB Cabergoline, Ro radiotherapy, SSA somatostatin analogs